• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙酰唑胺对钌(ii)对异丙基苯配合物的多功能配位作用及初步细胞毒性研究。

Versatile coordination of acetazolamide to ruthenium(ii) p-cymene complexes and preliminary cytotoxicity studies.

机构信息

Dipartimento di Chimica e Chimica Industriale, Università di Pisa, Via G. Moruzzi 13, I-56124 Pisa, Italy.

出版信息

Dalton Trans. 2018 Jul 17;47(28):9367-9384. doi: 10.1039/c8dt01555d.

DOI:10.1039/c8dt01555d
PMID:29951658
Abstract

The carbonic anhydrase inhibitor acetazolamide (AcmH2) reacted with [(η6-p-cymene)RuCl(μ-Cl)]2 to afford [(η6-p-cymene)RuCl2(κN-AcmH2)], 1A, in near-quantitative yield. In methanol, 1A exists in equilibrium with 1B, being probably a coordination isomer, as established by VT 1H-EXSY NMR spectroscopy. DFT calculations pointed to a higher stability of 1A with respect to 1B. [(η6-p-cymene)RuCl(κ2N,N'-AcmH)], 2, was obtained in 86% yield from [(η6-p-cymene)RuCl(μ-Cl)]2 and AcmH2 in the presence of NaOH. The reactions of 2 with AgNO3 (in water), pta/AgNO3 or pta/AgOTf/Et3N (in methanol) afforded the nitrate-coordinated complex [(η6-p-cymene)Ru(κO-NO3)(κ2N,N'-AcmH)], 3, the salt [(η6-p-cymene)Ru(κ2N,N'-AcmH)(κP-pta)]NO3, [4]NO3, and the zwitterion [(η6-p-cymene)Ru(κ2N,N'-Acm)(κP-pta)], 5, respectively, in high yields (pta = 1,3,5-triaza-7-phosphatricyclo[3.3.1.1]decane). The reactions of 5 with Brønsted acids yielded the protonated-pta species [(η6-p-cymene)Ru(κ2N,N'-Acm)(κP-ptaH)]X [6]X (X = NO3, TsO). All compounds were fully characterized by analytical and spectroscopic methods, and the structures of 1A, 2 and 5 were elucidated by X-ray diffraction. The stability of the compounds was investigated in aqueous media and 2 and 5 were evaluated for their cytotoxicity towards human ovarian A2780 and A2780cisR cancer cells and non-tumorigenic HEK-293 cells.

摘要

碳酸酐酶抑制剂乙酰唑胺 (AcmH2) 与 [(η6-p-cymene)RuCl(μ-Cl)]2 反应,几乎定量得到 [(η6-p-cymene)RuCl2(κN-AcmH2)], 1A。在甲醇中,1A 与 1B 处于平衡状态,可能是配位异构体,这一点通过 VT 1H-EXSY NMR 光谱得到了确立。DFT 计算表明 1A 比 1B 更稳定。[(η6-p-cymene)RuCl(κ2N,N'-AcmH)], 2,由 [(η6-p-cymene)RuCl(μ-Cl)]2 和 AcmH2 在 NaOH 的存在下以 86%的产率得到。2 与 AgNO3(在水中)、pta/AgNO3 或 pta/AgOTf/Et3N(在甲醇中)的反应分别得到了硝配位的配合物 [(η6-p-cymene)Ru(κO-NO3)(κ2N,N'-AcmH)], 3、盐 [(η6-p-cymene)Ru(κ2N,N'-AcmH)(κP-pta)]NO3 [4]NO3 和两性离子 [(η6-p-cymene)Ru(κ2N,N'-Acm)(κP-pta)], 5,产率均较高(pta = 1,3,5-三氮杂-7-磷杂环戊烷)。5 与布朗斯台德酸的反应得到了质子化的 pta 物种 [(η6-p-cymene)Ru(κ2N,N'-Acm)(κP-ptaH)]X [6]X(X = NO3, TsO)。所有化合物均通过分析和光谱方法进行了充分的表征,1A、2 和 5 的结构通过 X 射线衍射得到了阐明。在水介质中研究了化合物的稳定性,并评估了 2 和 5 对人卵巢 A2780 和 A2780cisR 癌细胞和非肿瘤性 HEK-293 细胞的细胞毒性。

相似文献

1
Versatile coordination of acetazolamide to ruthenium(ii) p-cymene complexes and preliminary cytotoxicity studies.乙酰唑胺对钌(ii)对异丙基苯配合物的多功能配位作用及初步细胞毒性研究。
Dalton Trans. 2018 Jul 17;47(28):9367-9384. doi: 10.1039/c8dt01555d.
2
Role of the (pseudo)halido ligand in ruthenium(II) -cymene α-amino acid complexes in speciation, protein reactivity and cytotoxicity.(假)卤化物配体在钌 (II)- 蒎烷 α- 氨基酸配合物形态分析、蛋白质反应性和细胞毒性中的作用。
Dalton Trans. 2021 Nov 9;50(43):15760-15777. doi: 10.1039/d1dt03274g.
3
α-Diimines as Versatile, Derivatizable Ligands in Ruthenium(II) p-Cymene Anticancer Complexes.α-二亚胺作为钌(II)对伞花烃抗癌配合物中多功能、可衍生化的配体。
Inorg Chem. 2018 Jun 4;57(11):6669-6685. doi: 10.1021/acs.inorgchem.8b00882. Epub 2018 May 23.
4
DNA targeting half sandwich Ru(II)--cymene-N^N complexes as cancer cell imaging and terminating agents: influence of regioisomers in cytotoxicity.DNA 靶向半三明治钌(II)--莰烯-N^N 配合物作为癌细胞成像和终止剂:区域异构体对细胞毒性的影响。
Dalton Trans. 2021 Jan 27;50(3):979-997. doi: 10.1039/d0dt03107k.
5
Coordination-driven self-assembly of ruthenium(ii) architectures: synthesis, characterization and cytotoxicity studies.配位驱动的钌(II)结构的自组装:合成、表征和细胞毒性研究。
Dalton Trans. 2018 Jun 25;47(25):8466-8475. doi: 10.1039/c8dt00962g.
6
Ru( p-cymene) Compounds as Effective and Selective Anticancer Candidates with No Toxicity in Vivo.钌(对伞花烃)化合物是有效的、选择性的抗癌候选物,在体内无毒性。
Inorg Chem. 2018 Nov 5;57(21):13150-13166. doi: 10.1021/acs.inorgchem.8b01270. Epub 2018 Oct 19.
7
Tuning the cytotoxicity of ruthenium(ii) para-cymene complexes by mono-substitution at a triphenylphosphine/phenoxydiphenylphosphine ligand.通过在三苯基膦/苯氧基二苯基膦配体上进行单取代来调节钌(II)对异丙基苯配合物的细胞毒性。
Dalton Trans. 2017 Dec 21;46(47):16589-16604. doi: 10.1039/c7dt03385k. Epub 2017 Nov 22.
8
Comparative solution equilibrium studies of antitumor ruthenium(η-p-cymene) and rhodium(η-CMe) complexes of 8-hydroxyquinolines.抗肿瘤钌(η-p-环戊二烯)和铑(η-CMe)配合物的 8-羟基喹啉的比较溶液平衡研究。
Dalton Trans. 2017 Mar 27;46(13):4382-4396. doi: 10.1039/c7dt00439g.
9
Luminescent anticancer Ru(II)-arenebipyridine and phenanthroline complexes: Synthesis, characterization, DFT studies, biological interactions and cellular imaging application.发光抗癌钌(II)-芳烃联吡啶和菲咯啉配合物:合成、表征、密度泛函理论研究、生物相互作用及细胞成像应用
J Inorg Biochem. 2020 Jul;208:111099. doi: 10.1016/j.jinorgbio.2020.111099. Epub 2020 May 16.
10
Highly active neutral ruthenium(II) arene complexes: synthesis, characterization, and investigation of their anticancer properties.高活性中性钌(II)芳环配合物的合成、表征及其抗癌性能研究。
J Inorg Biochem. 2012 Aug;113:77-82. doi: 10.1016/j.jinorgbio.2012.04.003. Epub 2012 Apr 12.

引用本文的文献

1
Triazine Chalcogenones from Thiocyanate or Selenocyanate Addition to Tetrazine Ligands in Ruthenium Arene Complexes.三嗪杂环酮的合成:钌芳烃配合物中硫氰酸根或硒氰酸根对四嗪配体的加成反应。
Inorg Chem. 2023 May 22;62(20):7814-7833. doi: 10.1021/acs.inorgchem.3c00459. Epub 2023 May 11.
2
Ruthenium(II)-Tris-pyrazolylmethane Complexes Inhibit Cancer Cell Growth by Disrupting Mitochondrial Calcium Homeostasis.钌(II)-三吡唑基甲烷配合物通过破坏线粒体钙稳态抑制癌细胞生长。
J Med Chem. 2022 Aug 11;65(15):10567-10587. doi: 10.1021/acs.jmedchem.2c00722. Epub 2022 Aug 1.
3
Novel Papaverine Metal Complexes with Potential Anticancer Activities.
新型罂粟碱金属配合物具有潜在的抗癌活性。
Molecules. 2020 Nov 20;25(22):5447. doi: 10.3390/molecules25225447.
4
Zinc-Containing Metalloenzymes: Inhibition by Metal-Based Anticancer Agents.含锌金属酶:金属基抗癌剂的抑制作用
Front Chem. 2020 May 19;8:402. doi: 10.3389/fchem.2020.00402. eCollection 2020.
5
Synthesis and Anticancer Activity of [RuCl(η-arene)(aroylthiourea)] Complexes-High Activity against the Human Neuroblastoma (IMR-32) Cancer Cell Line.[RuCl(η-芳烃)(芳酰基硫脲)]配合物的合成及其抗癌活性——对人神经母细胞瘤(IMR-32)癌细胞系具有高活性
ACS Omega. 2019 Apr 4;4(4):6245-6256. doi: 10.1021/acsomega.9b00349. eCollection 2019 Apr 30.
6
New sulfonamides containing organometallic-acylhydrazones: synthesis, characterisation and biological evaluation as inhibitors of human carbonic anhydrases.新型含有机金属酰腙的磺酰胺类化合物的合成、表征及作为人碳酸酐酶抑制剂的生物评价。
J Enzyme Inhib Med Chem. 2019 Dec;34(1):451-458. doi: 10.1080/14756366.2018.1555156.
7
Organoruthenium(II) complexes of acetazolamide potently inhibit human carbonic anhydrase isoforms I, II, IX and XII.乙酰唑胺的有机钌(II)配合物能强烈抑制人碳酸酐酶同工酶 I、II、IX 和 XII。
J Enzyme Inhib Med Chem. 2019 Dec;34(1):388-393. doi: 10.1080/14756366.2018.1547288.